|
TMEM49 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
1.061760E-03 |
| Normal-vs-Stage3 |
7.999200E-04 |
| Normal-vs-Stage4 |
1.117770E-01 |
| Stage1-vs-Stage2 |
4.650000E-01 |
| Stage1-vs-Stage3 |
4.860100E-02 |
| Stage1-vs-Stage4 |
4.683200E-01 |
| Stage2-vs-Stage3 |
8.972500E-02 |
| Stage2-vs-Stage4 |
6.350600E-01 |
| Stage3-vs-Stage4 |
2.877000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
5.58610002698856E-09 |
| Normal-vs-Asian |
7.781500E-02 |
| Caucasian-vs-AfricanAmerican |
4.123200E-01 |
| Caucasian-vs-Asian |
6.664600E-01 |
| AfricanAmerican-vs-Asian |
8.709600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
2.24642526802654E-12 |
| Male-vs-Female |
8.056200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.806070E-04 |
| Normal-vs-Extreme_Weight |
1.68154379309726E-12 |
| Normal-vs-Obese |
6.72980005056445E-09 |
| Normal-vs-Extreme_Obese |
4.464400E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.108600E-01 |
| Normal_Weight-vs-Obese |
6.409000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.067400E-01 |
| Extreme_Weight-vs-Obese |
5.511000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.494800E-01 |
| Obese-vs-Extreme_Obese |
9.983800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.56738000000045E-05 |
| Normal-vs-Age(41-60Yrs) |
1.62825308791525E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
4.062100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.087600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.009040E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.810200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.173800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.759840E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.544800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.343610E-03 |
| Normal-VS-KIRP CIMP |
3.760300E-03 |
| Normal-VS-Unclassified PRCC |
2.37719999995889E-06 |
| Type1 PRCC-VS-Type2 PRCC |
6.245700E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.655600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.503700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.269400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.260200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.926400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.95830000390995E-08 |
| Normal-vs-N1 |
2.212000E-02 |
| Normal-vs-N2 |
1.070360E-01 |
| N0-vs-N1 |
4.943400E-01 |
| N0-vs-N2 |
3.904800E-01 |
| N1-vs-N2 |
9.501600E-01 |
|
|
